YP

Yukta Panjwani

Director Director DIN 05164008
DIN 05164008 First appointment Jan 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2012
Shareholding value Locked Premium profile

About Yukta Panjwani

Yukta Panjwani has 14 years in corporate governance. Formerly with 1 company, such as Socrus Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

DIN 05164008
Primary Designation Director
First Appointment 04 Jan 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Socrus Pharmaceuticals Limited U24232MP1986PLC003300
Additional Director 04 Jan 2012 1986 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Socrus Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Yukta Panjwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yukta Panjwani

Yukta Panjwani has 14 years in corporate governance. Formerly with 1 company, such as Socrus Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.

Yukta Panjwani is associated with 0 companies as a director.

Yukta Panjwani has expertise in General Business.

Yukta Panjwani has 14 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available